Loading provider…
Loading provider…
Nephrology Physician in Bakersfield, CA
NPI: 1053363663Primary Practice Location
Bakersfield Oak St Dialysis
8331 Brimhall Rd, Bakersfield, CA
Primary Employer
Premier Urgent Care of Central California
premiermedicalgp.com
HQ Phone
Get M.D. Harjeet's Phone Numberphone_androidMobile
Get M.D. Harjeet's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
2006 - 2025

American Board of Internal Medicine
Internal Medicine
University of Mississippi Medical Center
umc.edu
Fellowship • Nephrology
2004 - 2006
Zucker School of Medicine at Hofstra/Northwell at Forest Hills Hospital
Residency • Internal Medicine
2001 - 2004
Guru Govind Singh Medical College
Medical School
Until 1992
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 122 | 200 |
| 2 | 99490Chronic care management services at least 20 minutes per calendar month | 75 | 86 |
| 3 | G0442Annual alcohol misuse screening, 15 minutes | 53 | 53 |
| 4 | G0444Annual depression screening, 15 minutes | 51 | 51 |
| 5 | 99213Established patient office or other outpatient visit, typically 15 minutes | 24 | 28 |
Volume-related weight gain and subsequent mortality in acute renal failure patients treated with continuous renal replacement therapy.
Authors: Tibor Fülöp, Minesh B. Pathak, Darren Schmidt, Zsolt Lengvárszky, Julio P. Juncos
Predictors of mortality in a cohort of intensive care unit patients with acute renal failure receiving continuous renal replacement therapy.
Authors: Harjeet Brar, Jake Olivier, Chris Lebrun, Will Gabbard, Tibor Fülöp
Lead Sponsor: Verona Pharma plc
Collaborators: Iqvia Pty Ltd
Intervention / Treatment: DRUG: Placebo, DRUG: Ensifentrine
Lead Sponsor: GlaxoSmithKline
Intervention / Treatment: DRUG: Iron therapy, DRUG: Darbepoetin alfa, DRUG: Daprodustat
Lead Sponsor: GlaxoSmithKline
Intervention / Treatment: DRUG: Placebo, DRUG: Darbepoetin alfa, DRUG: Iron Therapy, DRUG: Daprodustat